Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.07 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.08 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.08 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.08 |